These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1852111)

  • 1. Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon.
    Pavoine C; Brechler V; Kervran A; Blache P; Le-Nguyen D; Laurent S; Bataille D; Pecker F
    Am J Physiol; 1991 May; 260(5 Pt 1):C993-9. PubMed ID: 1852111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic actions of glucagon and miniglucagon on Ca2+ mobilization in cardiac cells.
    Sauvadet A; Rohn T; Pecker F; Pavoine C
    Circ Res; 1996 Jan; 78(1):102-9. PubMed ID: 8603492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide decreases contractility of cultured chick ventricular cells.
    Vaxelaire JF; Laurent S; Lacolley P; Briand V; Schmitt H; Michel JB
    Life Sci; 1989; 45(1):41-8. PubMed ID: 2473367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
    MacDonell KL; Diamond J
    Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
    Juan-Fita MJ; Vargas ML; Hernández J
    Eur J Pharmacol; 2005 Apr; 512(2-3):207-13. PubMed ID: 15840406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atrial natriuretic factor diminishes the contractility of the cardiac cell in culture].
    Vaxelaire JF; Laurent S; Briand V; Michel JB; Schmitt H
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():271-3. PubMed ID: 2461183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon increases contractility in ventricle but not in atrium of the rat heart.
    Gonzalez-Muñoz C; Nieto-Cerón S; Cabezas-Herrera J; Hernández-Cascales J
    Eur J Pharmacol; 2008 Jun; 587(1-3):243-7. PubMed ID: 18474367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway.
    Dalle S; Smith P; Blache P; Le-Nguyen D; Le Brigand L; Bergeron F; Ashcroft FM; Bataille D
    J Biol Chem; 1999 Apr; 274(16):10869-76. PubMed ID: 10196164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine inhibits positive inotropic effect of cholera toxin in ventricular muscle.
    Pappano AJ; Hartigan PM; Coutu MD
    Am J Physiol; 1982 Sep; 243(3):H434-41. PubMed ID: 6287867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of C-type natriuretic peptide on rat cardiac contractility.
    Brusq JM; Mayoux E; Guigui L; Kirilovsky J
    Br J Pharmacol; 1999 Sep; 128(1):206-12. PubMed ID: 10498853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.
    Böhm M; Brückner R; Hackbarth I; Haubitz B; Linhart R; Meyer W; Schmidt B; Schmitz W; Scholz H
    J Pharmacol Exp Ther; 1984 Aug; 230(2):483-92. PubMed ID: 6086891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of atrial natriuretic peptide and angiotensin II on the myocardium: studies in isolated rat ventricular cardiomyocytes.
    Neyses L; Vetter H
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1435-43. PubMed ID: 2551288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid drives mini-glucagon action in cardiac cells.
    Sauvadet A; Rohn T; Pecker F; Pavoine C
    J Biol Chem; 1997 May; 272(19):12437-45. PubMed ID: 9139691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polypeptide (AP-A) from sea anemone (Anthopleura xanthogrammica) with potent positive inotropic action.
    Shibata S; Norton TR; Izumi T; Matsuo T; Katsuki S
    J Pharmacol Exp Ther; 1976 Nov; 199(2):298-309. PubMed ID: 10426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium.
    Juan-Fita MJ; Vargas ML; Kaumann AJ; Hernández Cascales J
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):324-9. PubMed ID: 15452686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness to glucagon in fetal hearts. Species variability and apparent disparities between changes in beating, adenylate cyclase activation, and cyclic AMP concentration.
    Wildenthal K; Allen DO; Karlsson J; Wakeland JR; Clark CM
    J Clin Invest; 1976 Mar; 57(3):551-8. PubMed ID: 175087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is cAMP not cAMP? Effects of compartmentalization.
    Bers DM; Ziolo MT
    Circ Res; 2001 Aug; 89(5):373-5. PubMed ID: 11532895
    [No Abstract]   [Full Text] [Related]  

  • 18. Atrial natriuretic peptide decreases contractility of cultured heart cell: preliminary report.
    Vaxelaire JF; Laurent S; Briand V; Michel JB; Schmitt H
    J Hypertens Suppl; 1988 Dec; 6(4):S282-3. PubMed ID: 2467972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGMP elevation does not mediate muscarinic agonist-induced negative inotropy in rat ventricular cardiomyocytes.
    MacDonell KL; Tibbits GF; Diamond J
    Am J Physiol; 1995 Dec; 269(6 Pt 2):H1905-12. PubMed ID: 8594898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxing effect of pharmacologic interventions increasing cAMP in rat heart.
    Vittone L; Grassi A; Chiappe L; Argel M; Cingolani HE
    Am J Physiol; 1981 Apr; 240(4):H441-7. PubMed ID: 6261590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.